company

NEVROKIRO INVEST AS

1369 STABEKK

Return on Equity
8,16 %
Current Ratio
1,22
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue0
Net Income498 000
Total Assets33 919 000
Total Equity6 103 000
Income (NOK)2022
Revenue0
Expenditure587 000
Operating Profit−587 000
Financial Income6 531 000
Financial Costs5 447 000
Financial Balance1 084 000
Earnings Before Tax498 000
Tax0
Net Income498 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets33 919 000
Total Assets33 919 000
Total Retained Equity5 623 000
Total Equity6 103 000
Total Long-Term Debt0
Total Current Debt27 816 000
Total Equity and Debt33 919 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure587 000
Operating Profit−587 000
Financial Income6 531 000
Financial Costs5 447 000
Financial Balance1 084 000
Dividends0
Net Income498 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments33 919 000
Cash, Bank0
Total Current Assets33 919 000
Total Assets33 919 000
Total Equity6 103 000
Short-Term Group Debt21 372 000
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt2 410 000
Total Current Debt27 816 000
Total Equity and Debt33 919 000
Financial indicators2022
Return on Equity8,16 %
Debt-to-Equity Ratio0
Operating Profit Margin-
Current Ratio1,22
Quick Ratio1,22
Equity Ratio0,18
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English